REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro Neuroradioncologico de Cartagena S.A.S. (Colombia)

Main Activities: General Medical and Surgical Hospitals
Full name: Centro Neuroradioncologico de Cartagena S.A.S. Profile Updated: January 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Centro Neuroradioncologico de Cartagena S.A.S. is an enterprise based in Colombia. Its main office is in Cartagena. The company operates in the General Medical and Surgical Hospitals sector. The enterprise was incorporated on May 26, 2011. The total number of employees is currently 9 (2023). The latest financial highlights indicate a net sales revenue increase of 17.53% in 2023. Its’ total assets recorded a growth of 10.96%. The net profit margin of Centro Neuroradioncologico de Cartagena S.A.S. increased by 10.07% in 2023.

Headquarters
Dg 40 Cr 81 31
Cartagena; Bolivar;

Contact Details: Purchase the Centro Neuroradioncologico de Cartagena S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Centro Neuroradioncologico de Cartagena S.A.S. report to view the information.
Outstanding Shares:
Purchase the Centro Neuroradioncologico de Cartagena S.A.S. report to view the information.
Incorporation Date:
May 26, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro Neuroradioncologico de Cartagena S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
17.53%
Total operating revenue
17.53%
Operating profit (EBIT)
144.2%
EBITDA
143.56%
Net Profit (Loss) for the Period
100.39%
Total assets
10.96%
Total equity
68.87%
Operating Profit Margin (ROS)
19.48%
Net Profit Margin
10.07%
Return on Equity (ROE)
12.8%
Quick Ratio
0.23%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?